VALEANT PHARMACEUTICALS INTE's ticker is and the CUSIP is 91911K953. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTE in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,189,000 | -97.9% | 5,986 | -98.5% | 0.00% | -100.0% |
| Q4 2014 | $57,330,000 | +1148.5% | 400,600 | +1044.6% | 0.01% | +1200.0% |
| Q3 2014 | $4,592,000 | +450.6% | 35,000 | +393.0% | 0.00% | – |
| Q4 2013 | $834,000 | +12.7% | 7,100 | 0.0% | 0.00% | – |
| Q3 2013 | $740,000 | +20.9% | 7,100 | 0.0% | 0.00% | – |
| Q2 2013 | $612,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 7,100 | $740,000 | 0.00% |